{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01946048",
      "OrgStudyIdInfo": {
        "OrgStudyId": "12276102D-Cardiac Disease"
      },
      "Organization": {
        "OrgFullName": "Hebei Medical University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy",
      "OfficialTitle": "Safety and Efficacy Investigation of Patients With Ischemic Cardiomyopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2013",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 2013",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2014",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "September 12, 2013",
      "StudyFirstSubmitQCDate": "September 16, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "September 19, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "October 5, 2013",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 8, 2013",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Quanhai Li",
        "ResponsiblePartyInvestigatorTitle": "Director of Cell Thearpy Center, the First Hospital of HeibeiMU",
        "ResponsiblePartyInvestigatorAffiliation": "Hebei Medical University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Hebei Medical University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy .",
      "DetailedDescription": "Coronary artery disease (CAD) is a common disorder that can lead to heart failure. Not all people with CAD are eligible for today's standard treatments. One new treatment approach uses umbilical cord blood derived mesenchymal stem cells-specialized cells capable of developing into other types of cells-to stimulate growth of new blood vessels for the heart. The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy ."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Ischemic Cardiomyopathy"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Stem cells implantation Patients with severe coronary artery disease with ischemic cardiomyopathy managed with intramyocardial administration of allogeneic mesenchymal stem cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "mesenchymal stem cells",
            "InterventionDescription": "Procedure: Selected patients were randomly divided into a cell therapy group and a control group.\n\nUmbilical Cord Blood Derived Mesenchymal Stem Cells at a dose of 150-250 million.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "The examination of heart function",
            "PrimaryOutcomeDescription": "Left ventricular ejection fractionï¼š Change in left ventricular ejection fraction assessed with echocardiography after intramyocardial implantation of allogeneic mesenchymal stem cells.",
            "PrimaryOutcomeTimeFrame": "Post cell transplantation: 1, 3, 6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "all-cause mortality",
            "SecondaryOutcomeTimeFrame": "Post cell transplantation: one year"
          },
          {
            "SecondaryOutcomeMeasure": "all-cause morbidity",
            "SecondaryOutcomeTimeFrame": "Post cell transplantation: one year"
          },
          {
            "SecondaryOutcomeMeasure": "major adverse cardiac and cerebrovascular events",
            "SecondaryOutcomeTimeFrame": "Post cell transplantation: one year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge from 30 to 80 years\nischemic cardiomyopathy\nLeft ventricular infarction area seriously low movement to no movement\nThe low whole left ventricular systolic function (LVEF 45% or less)\nHave line or quasi coronary interventional treatment\nWilling to accept patients with follow-up evaluation\nHave signed informed consent form approved by the ethics committee\n\nExclusion Criteria:\n\nNon elevation between S-wave and T-wave in patients with acute myocardial infarction\nNo function damage in patients with acute myocardial infarction\nAcute myocardial infarction complicated with left ventricular aneurysm intends to do surgery\nComplications of acute myocardial infarction with other machines (including: ventricular septal perforation, papillary muscle rupture, etc.)\nAcute infectious diseases\nBlood system diseases, such as thrombocytopenia, severe anemia, leukemia, etc\nSevere renal disease, creatinine clearance < 36 ml/min, serum creatinine > 265 umol/L\nLaboratory tests suggest abnormal liver function, glutamate-pyruvate transaminase (ALT) > 4 times the upper limit of normal\nUnstable cerebral lesions\nmalignant tumor\nCognitive dysfunction and dementia patients, patients with severe mental illness\nPatients with severe physical disabilities can't regular follow-up\nOther serious uncontrolled system disease\nTo prepare or have the pregnancy women patients\nHave a percutaneous coronary intervention contraindications: high-risk patients, such as the digestive tract, and intracranial hemorrhage or contrast allergy\nCannot use the test dose atorvastatin\nIs not completed in accordance with the requirements for test the timing of the magnetic resonance imaging (MRI), PET, SPECT, follow-up testing (e.g., patients with implanted pacemakers or artificial joint)\nPatients unable or unwilling to sign a consent form",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "30 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Baoyong Yan, Doctor",
            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Gang Liu, Doctor",
            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Guoping Ma, Master",
            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Jun Zhang, Master",
            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "the First Hospital of Hebei Medical University",
            "LocationCity": "Shijiazhuang",
            "LocationState": "Hebei",
            "LocationZip": "050000",
            "LocationCountry": "China"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009202",
            "ConditionMeshTerm": "Cardiomyopathies"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemic",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11306",
            "ConditionBrowseLeafName": "Cardiomyopathies",
            "ConditionBrowseLeafAsFound": "Cardiomyopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          }
        ]
      }
    }
  }
}